(Q36722548)

English

Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study

scientific article published on 11 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Quan Dong Nguyen

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Mohamed A Ibrahim

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Anthony Watters

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Millena Bittencourt

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jithin Yohannan

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Yasir J Sepah

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

James P Dunn

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Joel Naor

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Naveed Shams

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Ovais Shaikh

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Henry Alexander Leder

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Diana V Do

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

11 February 2013

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Journal of ophthalmic inflammation and infection

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

32

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1186/1869-5760-3-32

0 references

Managing stomatitis in patients treated with Mammalian target of rapamycin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Subconjunctival sirolimus in the treatment of diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Common toxicities of mammalian target of rapamycin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Cyclophosphamide for ocular inflammatory diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Sirolimus-induced pneumonitis following liver transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

The efficacy of sirolimus in the treatment of patients with refractory uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Degree, duration, and causes of visual loss in uveitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Solubilizing excipients in oral and injectable formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Sirolimus: a comprehensive review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

From beach to bedside: history of the development of sirolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Development of the 25-item National Eye Institute Visual Function Questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Immunological abnormalities in patients with untreated retinal vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

30 September 2017

Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

28 June 2018

Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

28 June 2018

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

5 September 2018

Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

5 September 2018

A central role for inflammation in the pathogenesis of diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

5 September 2018

Is diabetic retinopathy an inflammatory disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610181

5 September 2018

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23514595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/23514595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cell adhesion molecules in posterior uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23514595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian toxicity from sirolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23514595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23514595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23514595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization of vitreal inflammatory activity in intermediate and posterior uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23514595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1869-5760-3-32

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36722548&oldid=1516337868"